JMAR to Showcase BioSentry(TM) Water Quality Monitoring Device at Seatrade Cruise Shipping Convention 2006
BioSentry is a contamination warning system for waterborne microorganisms. Whereas current water monitoring depends on batch sampling of water and time consuming lab analysis, BioSentry uses laser-based technology to provide continuous, online, real-time monitoring for harmful bacteria and protozoa. BioSentry is targeted towards a number of applications across multiple industries, including municipal drinking water utilities, the beverage industry, and homeland security. The BioSentry booth will be located in Hall D, display unit number 3052.
The Seatrade Cruise Shipping Convention is recognized as the leading industry event and serves as a meeting place for quality cruise line visitors and cruise industry suppliers. For additional information and a complete list of conference attendees, please visit www.cruiseshipping.net.
About Hyde Marine, Inc.
Hyde Marine, Inc. is developing other technologies for shipboard security solutions including water cannon deterrent systems for cruise ships and real-time detection systems for undesirable waterborne organisms. Hyde is also a major supplier of shipboard environmental equipment including ballast water treatment, UV disinfection, waste water treatment, oil water separation, and ballast tank sediment control systems as well as other types of shipboard machinery and equipment. Hyde Marine and its joint venture company, Lamor LLC, manufacture and market oil spill response equipment internationally and work with organizations to develop and enhance their response capabilities. Additional information is available at http://www.hydemarine.com and http://www.lamor.com, by telephone at (440) 871-8000, or via e-mail at email@example.com.
JMAR Technologies, Inc. is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging more than a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries while continuing to carry out research and development for the U.S. Defense Advanced Research Projects Agency (DARPA) and support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotechnology, bioscience and semiconductor industries with its BriteLight(TM) Laser; X-ray Light Source; Compact X-ray Microscope -- for 3D visualization of single cells and polymers; and X-ray Nano Probe -- enabling interaction, analysis and materials modification at the nano-scale. JMAR also develops, manufactures and markets its BioSentry(TM) microorganism early-warning system and maintains a strategic alliance for the production of the READ chemical sensor for the homeland security, environmental and utility infrastructure industries.
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the risk that the performance validation tests of the BioSentry Beta units are not successfully completed due to unforeseen issues with the installation and operation of the units outside of the controlled environment of JMAR's facility, delays in completion of the X-ray Microscope and X-ray Nano Probe prototypes and transition to production units, the failure of the technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets , cost and margins for JMAR's products, failure to obtain market acceptance, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-Q for the quarter ended September 30, 2005 and its Form 8-K filed on March 30, 2005 with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.